Inogen | INGN - Operating Expenses


Inogen reported $49.14M in Operating Expenses for its fiscal quarter ending in September of 2024.





Operating Expenses Change Date
Abbott USD 9.31B 104M Mar/2026
Accuray USD 37.18M 567K Dec/2024
AngioDynamics USD 81.95M 1.68M Sep/2025
Artivion USD 111.2M 9.45M Dec/2025
AtriCure USD 140.72M 2.71M Mar/2026
Baxter International USD 6.04B 2.85B Mar/2026
Becton, Dickinson and Co. USD 4.59B 476M Dec/2025
Boston Scientific USD 4.15B 107M Mar/2026
Chart Industries USD 954.5M 31.4M Dec/2025
Cooper Companies USD 811.3M 113.5M Dec/2025
Dexcom USD 936.6M 0 Mar/2026
Edwards Lifesciences USD 1.13B 65.4M Mar/2026
Globus Medical USD 645.11M 241.46M Dec/2025
Inogen USD 49.14M 665K Sep/2024
Insulet USD 637.5M 48.9M Dec/2025
Masimo USD 328.6M 181.6M Dec/2025
Medtronic USD 7.28B 16M Dec/2025
Orthofix International USD 213.79M 12.36M Dec/2025
Philips EUR 4.38B 405M Dec/2025
ResMed USD 925.74M 525K Mar/2026
Steris USD 1.22B 28.8M Dec/2025
Stryker USD 4.92B 284M Mar/2026
Tandem Diabetes Care USD 282.09M 9.97M Dec/2025
Teleflex USD 532.64M 3.29B Dec/2025
X T L Biopharmaceuticals USD 1.1M 175K Dec/2024
Zimmer Biomet Holdings USD 1.69B 249.3M Mar/2026